Literature DB >> 27022196

Cutting Edge: BAFF Promotes Autoantibody Production via TACI-Dependent Activation of Transitional B Cells.

Holly M Jacobs1, Christopher D Thouvenel1, Sarah Leach1, Tanvi Arkatkar1, Genita Metzler2, Nicole E Scharping1, Nikita S Kolhatkar2, David J Rawlings3, Shaun W Jackson4.   

Abstract

Mice overexpressing B cell activating factor of the TNF family (BAFF) develop systemic autoimmunity characterized by class-switched anti-nuclear Abs. Transmembrane activator and CAML interactor (TACI) signals are critical for BAFF-mediated autoimmunity, but the B cell developmental subsets undergoing TACI-dependent activation in settings of excess BAFF remain unclear. We report that, although surface TACI expression is usually limited to mature B cells, excess BAFF promotes the expansion of TACI-expressing transitional B cells. TACI(+) transitional cells from BAFF-transgenic mice are characterized by an activated, cycling phenotype, and the TACI(+) cell subset is specifically enriched for autoreactivity, expresses activation-induced cytidine deaminase and T-bet, and exhibits evidence of somatic hypermutation. Consistent with a potential contribution to BAFF-mediated humoral autoimmunity, TACI(+) transitional B cells from BAFF-transgenic mice spontaneously produce class-switched autoantibodies ex vivo. These combined findings highlight a novel mechanism through which BAFF promotes humoral autoimmunity via direct, TACI-dependent activation of transitional B cells.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27022196      PMCID: PMC4868625          DOI: 10.4049/jimmunol.1600017

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.

Authors:  J S Thompson; S A Bixler; F Qian; K Vora; M L Scott; T G Cachero; C Hession; P Schneider; I D Sizing; C Mullen; K Strauch; M Zafari; C D Benjamin; J Tschopp; J L Browning; C Ambrose
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

2.  Regulation of the T-independent humoral response by TACI.

Authors:  G U von Bülow; J M van Deursen; R J Bram
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

3.  Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation.

Authors:  D Allman; R C Lindsley; W DeMuth; K Rudd; S A Shinton; R R Hardy
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

4.  Activation and accumulation of B cells in TACI-deficient mice.

Authors:  M Yan; H Wang; B Chan; M Roose-Girma; S Erickson; T Baker; D Tumas; I S Grewal; V M Dixit
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

5.  Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c⁺ B-cell population is important for the development of autoimmunity.

Authors:  Anatoly V Rubtsov; Kira Rubtsova; Aryeh Fischer; Richard T Meehan; Joann Z Gillis; John W Kappler; Philippa Marrack
Journal:  Blood       Date:  2011-05-04       Impact factor: 22.113

Review 6.  Cracking the BAFF code.

Authors:  Fabienne Mackay; Pascal Schneider
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

7.  TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells.

Authors:  Laura S Treml; Gianluca Carlesso; Kristen L Hoek; Jason E Stadanlick; Taku Kambayashi; Richard J Bram; Michael P Cancro; Wasif N Khan
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

8.  The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88.

Authors:  Bing He; Raul Santamaria; Weifeng Xu; Montserrat Cols; Kang Chen; Irene Puga; Meimei Shan; Huabao Xiong; James B Bussel; April Chiu; Anne Puel; Jeanine Reichenbach; László Marodi; Rainer Döffinger; Julia Vasconcelos; Andrew Issekutz; Jens Krause; Graham Davies; Xiaoxia Li; Bodo Grimbacher; Alessandro Plebani; Eric Meffre; Capucine Picard; Charlotte Cunningham-Rundles; Jean-Laurent Casanova; Andrea Cerutti
Journal:  Nat Immunol       Date:  2010-08-01       Impact factor: 25.606

9.  Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.

Authors:  F Mackay; S A Woodcock; P Lawton; C Ambrose; M Baetscher; P Schneider; J Tschopp; J L Browning
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

10.  BAFF and MyD88 signals promote a lupuslike disease independent of T cells.

Authors:  Joanna R Groom; Carrie A Fletcher; Stacey N Walters; Shane T Grey; Sally V Watt; Mathew J Sweet; Mark J Smyth; Charles R Mackay; Fabienne Mackay
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

View more
  27 in total

Review 1.  BAFF inhibition in SLE-Is tolerance restored?

Authors:  Shaun W Jackson; Anne Davidson
Journal:  Immunol Rev       Date:  2019-09-28       Impact factor: 12.988

2.  Functional Characterization of CD11c+ Age-Associated B Cells as Memory B Cells.

Authors:  Samuel W Du; Tanvi Arkatkar; Fahd Al Qureshah; Holly M Jacobs; Christopher D Thouvenel; Kristy Chiang; Andrea D Largent; Quan-Zhen Li; Baidong Hou; David J Rawlings; Shaun W Jackson
Journal:  J Immunol       Date:  2019-10-21       Impact factor: 5.422

3.  Cutting Edge: BAFF Overexpression Reduces Atherosclerosis via TACI-Dependent B Cell Activation.

Authors:  Shaun W Jackson; Nicole E Scharping; Holly M Jacobs; Shari Wang; Alan Chait; David J Rawlings
Journal:  J Immunol       Date:  2016-11-11       Impact factor: 5.422

Review 4.  The Plasticity of Newly Formed B Cells.

Authors:  Natalia V Giltiay; Daniela Giordano; Edward A Clark
Journal:  J Immunol       Date:  2019-12-15       Impact factor: 5.422

Review 5.  Altered B cell signalling in autoimmunity.

Authors:  David J Rawlings; Genita Metzler; Michelle Wray-Dutra; Shaun W Jackson
Journal:  Nat Rev Immunol       Date:  2017-04-10       Impact factor: 53.106

Review 6.  Autoimmunity in Primary Immunodeficiencies (PID).

Authors:  Grace T Padron; Vivian P Hernandez-Trujillo
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-01       Impact factor: 8.667

7.  TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.

Authors:  Tanvi Arkatkar; Holly M Jacobs; Samuel W Du; Quan-Zhen Li; Kelly L Hudkins; Charles E Alpers; David J Rawlings; Shaun W Jackson
Journal:  Kidney Int       Date:  2018-06-12       Impact factor: 10.612

8.  Blockade of BAFF Reshapes the Hepatic B Cell Receptor Repertoire and Attenuates Autoantibody Production in Cholestatic Liver Disease.

Authors:  Manoj Thapa; Dana Tedesco; Sanjeev Gumber; Elizabeth J Elrod; Jin-Hwan Han; William H Kitchens; Joseph F Magliocca; Andrew B Adams; Arash Grakoui
Journal:  J Immunol       Date:  2020-04-24       Impact factor: 5.422

9.  Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells.

Authors:  Samuel W Du; Holly M Jacobs; Tanvi Arkatkar; David J Rawlings; Shaun W Jackson
Journal:  J Immunol       Date:  2018-10-29       Impact factor: 5.422

10.  Belimumab promotes negative selection of activated autoreactive B cells in systemic lupus erythematosus patients.

Authors:  Weiqing Huang; Tam D Quach; Cosmin Dascalu; Zheng Liu; Tungming Leung; Miranda Byrne-Steele; Wenjing Pan; Qunying Yang; Jian Han; Martin Lesser; Thomas L Rothstein; Richard Furie; Meggan Mackay; Cynthia Aranow; Anne Davidson
Journal:  JCI Insight       Date:  2018-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.